These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 38915409)

  • 1. Expansion of effector memory Vδ2
    Huang Y; Jiang C; Zhu J; Lin L; Mao M; Yin T; Cai G
    Front Immunol; 2024; 15():1397483. PubMed ID: 38915409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantation.
    Knight A; Madrigal AJ; Grace S; Sivakumaran J; Kottaridis P; Mackinnon S; Travers PJ; Lowdell MW
    Blood; 2010 Sep; 116(12):2164-72. PubMed ID: 20576814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus drives Vδ2neg γδ T cell inflation in many healthy virus carriers with increasing age.
    Alejenef A; Pachnio A; Halawi M; Christmas SE; Moss PA; Khan N
    Clin Exp Immunol; 2014 Jun; 176(3):418-28. PubMed ID: 24547915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells.
    Halary F; Pitard V; Dlubek D; Krzysiek R; de la Salle H; Merville P; Dromer C; Emilie D; Moreau JF; Déchanet-Merville J
    J Exp Med; 2005 May; 201(10):1567-78. PubMed ID: 15897274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower incidence of grade II-IV acute Graft-versus-Host-Disease in pediatric patients recovering with high Vδ2+ T cells after allogeneic stem cell transplantation with unmanipulated bone marrow grafts: a prospective single-center cohort study.
    Müller T; Alasfar L; Preuß F; Zimmermann L; Streitz M; Hundsdörfer P; Eggert A; Schulte J; von Stackelberg A; Oevermann L
    Front Immunol; 2024; 15():1433785. PubMed ID: 39136029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of γδ T Cells Predicts Cytomegalovirus Infection Resolution in Kidney Transplants.
    Kaminski H; Garrigue I; Couzi L; Taton B; Bachelet T; Moreau JF; Déchanet-Merville J; Thiébaut R; Merville P
    J Am Soc Nephrol; 2016 Feb; 27(2):637-45. PubMed ID: 26054538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation.
    Litjens NHR; van der Wagen L; Kuball J; Kwekkeboom J
    Front Immunol; 2018; 9():389. PubMed ID: 29545802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation.
    Couzi L; Pitard V; Moreau JF; Merville P; Déchanet-Merville J
    Front Immunol; 2015; 6():3. PubMed ID: 25653652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct activities of Vδ1
    Liu R; Wu N; Gao H; Liang S; Yue K; Dong T; Dong X; Xu LP; Wang Y; Zhang XH; Liu J; Huang XJ
    Immunology; 2022 Nov; 167(3):368-383. PubMed ID: 35795896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetramer monitoring to assess risk factors for recurrent cytomegalovirus reactivation and reconstitution of antiviral immunity post allogeneic hematopoietic stem cell transplantation.
    Borchers S; Luther S; Lips U; Hahn N; Kontsendorn J; Stadler M; Buchholz S; Diedrich H; Eder M; Koehl U; Ganser A; Mischak-Weissinger E
    Transpl Infect Dis; 2011 Jun; 13(3):222-36. PubMed ID: 21585633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic Cells Are Critical for the Activation and Expansion of Vδ2
    Wang X; Liu J; Gao H; Mo XD; Han T; Xu LP; Zhang XH; Huang XJ
    Front Immunol; 2018; 9():2528. PubMed ID: 30443256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation.
    Minculescu L; Marquart HV; Ryder LP; Andersen NS; Schjoedt I; Friis LS; Kornblit BT; Petersen SL; Haastrup E; Fischer-Nielsen A; Reekie J; Sengelov H
    Front Immunol; 2019; 10():1997. PubMed ID: 31507601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications.
    Tey SK; Kennedy GA; Cromer D; Davenport MP; Walker S; Jones LI; Crough T; Durrant ST; Morton JA; Butler JP; Misra AK; Hill GR; Khanna R
    PLoS One; 2013; 8(10):e74744. PubMed ID: 24146744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus infection alters phenotypes of different γδ T-cell subsets in renal transplant recipients with long-term stable graft function.
    Lee S; Affandi JS; Irish AB; Price P
    J Med Virol; 2017 Aug; 89(8):1442-1452. PubMed ID: 28198539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity transferred by infusion of cytomegalovirus-specific CD8(+) T cells within donor grafts: its associations with cytomegalovirus reactivation following unmanipulated allogeneic hematopoietic stem cell transplantation.
    Luo XH; Huang XJ; Liu KY; Xu LP; Liu DH
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):994-1004. PubMed ID: 20167279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics screening after pediatric allogenic hematopoietic stem cell transplantation reveals an association between increased expression of inhibitory receptor FCRL6 on γδ T cells and cytomegalovirus reactivation.
    Alexandersson A; Venäläinen MS; Heikkilä N; Huang X; Taskinen M; Huttunen P; Elo LL; Koskenvuo M; Kekäläinen E
    Immunol Cell Biol; 2024 Jul; 102(6):513-525. PubMed ID: 38726587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
    Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
    Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergent clonal selection of donor- and recipient-derived CMV-specific T cells in hematopoietic stem cell transplant patients.
    Erickson JR; Stevens-Ayers T; Mair F; Edmison B; Boeckh M; Bradley P; Prlic M
    Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35105810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.